Pages

Showing posts with label Methuselah Foundation. Show all posts
Showing posts with label Methuselah Foundation. Show all posts

Sunday, 31 October 2010

Is Defeating Aging Only a Dream? Is SENS pseudoscience?

reposted from: http://www.technologyreview.com/sens/ via Chapter 2, 'Ending Aging' by Aubrey De Grey.

Crabsallover says 'Are Aubrey De Greys' 'Strategies for Engineered Negligible Senescence (SENS) proposals sense or or just pseudo-scientific nonsense? A $20,000 challenge prize was offered jointly by MIT Technology Review and Methuselah Foundation to disprove Aubrey de Grey anti-aging SENS proposals and to show that they were so wrong that they were unworthy of learned debate. Independent judges of the challenge prize included Craig Venter (whose organisation successful sequenced the Human Genome in 2000) said "Estep et al. in my view have not demonstrated that SENS is unworthy of discussion, but the proponents of SENS have not made a compelling case for it."


No one has won our $20,000 Challenge to disprove Aubrey de Grey's anti-aging proposals.

Last year, Technology Review announced a $20,000 prize for any molecular biologist who could demonstrate that biogerontologist Aubrey de Grey's "Strategies for Engineered Negligible Senescence" (SENS) -- a much publicized prescription for defeating aging -- was "so wrong that it was unworthy of learned debate." The purpose of the challenge was to determine whether de Grey's proposals were science or fantasy.
The judges of the "SENS Challenge" were Rodney Brooks, the director of MIT's Computer Science and Artificial Intelligence Laboratory and the chief technology officer of iRobot; Anita Goel, the founder and chief executive of Nanobiosym; Vikram Kumar, the cofounder and chief executive of Dimagi and a pathologist at Brigham and Women's Hospital in Boston; Nathan Myhrvold, the cofounder and chief executive of Intellectual Ventures and the former chief technology officer of Microsoft; and J. Craig Venter, the founder and president of the Venter Institute, whose computational methods hastened the completion of the Human Genome Project.

We received five submissions, of which only three met the terms of the challenge. De Grey wrote a rebuttal to each qualifying submission, and the challengers wrote responses to those rebuttals. The judges considered all these documents.

In the end, the judges felt that no submission met the criterion of the challenge and disproved SENS, although they unanimously agreed that one submission, by Preston W. Estep and his colleagues, was the most eloquent. The judges also noted, however, that de Grey had not convincingly defended SENS and that many of his ideas seemed somewhat fanciful.

Nathan Myhrvold, writing for all the judges, offered this summary of their deliberations:
"At issue is the conflict between the scientific process and the ambiguous status of ideas that have not yet been subjected to that process.

"The scientific process requires evidence through independent experimentation or observation in order to accord credibility to a hypothesis. SENS is a collection of hypotheses that have mostly not been subjected to that process and thus cannot rise to the level of being scientifically verified. However, by the same token, the ideas of SENS have not been conclusively disproved. SENS exists in a middle ground of yet-to-be-tested ideas that some people may find intriguing but which others are free to doubt.

"Some scientists react very negatively toward those who seek to claim the mantle of scientific authority for ideas that have not yet been proved. Estep et al. seem to have this philosophy. They raise many reasons to doubt SENS. Their submission does the best job in that regard. But at the same time, they are too quick to engage in name-calling, labeling ideas as 'pseudo-scientific' or 'unscientific' that they cannot really demonstrate are so.
"We need to remember that all hypotheses go through a stage where one or a small number of investigators believe something and others raise doubts. The conventional wisdom is usually correct. But while most radical ideas are in fact wrong, it is a hallmark of the scientific process that it is fair about considering new propositions; every now and then, radical ideas turn out to be true. Indeed, these exceptions are often the most momentous discoveries in science.

"SENS has many unsupported claims and is certainly not scientifically proven. I personally would be surprised if de Grey is correct in the majority of his claims. However, I don't think Estep et al. have proved that SENS is false; that would require more research. In some cases, SENS makes claims that run parallel to existing research (while being more sensational). Future investigation into those areas will almost certainly illuminate the controversy. Until that time, people like Estep et al. are free to doubt SENS. I share many of those doubts, but it would be overstating the case to assert that Estep et al. have proved their point."

A majority of the judges also argued that if SENS was not exactly science, de Grey (a computer scientist by training) had described his proposals as a kind of engineering project -- and they upbraided Estep et al. for not considering them on those terms. Rodney Brooks wrote, "I have no confidence that they understand engineering, and some of their criticisms are poor criticisms of a legitimate engineering process."

Craig Venter most succinctly expressed the prevailing opinion. He wrote, "Estep et al. in my view have not demonstrated that SENS is unworthy of discussion, but the proponents of SENS have not made a compelling case for it."

In short, SENS is highly speculative. Many of its proposals have not been reproduced, nor could they be reproduced with today's scientific knowledge and technology. Echoing Myhrvold, we might charitably say that de Grey's proposals exist in a kind of antechamber of science, where they wait (possibly in vain) for independent verification. SENS does not compel the assent of many knowledgeable scientists; but neither is it demonstrably wrong.

Therefore, the challenge remains open. In recognition of their careful scholarship, however, Estep et al. will be paid half the value of the prize. (This represents the $10,000 that Technology Review pledged; the Methuselah Foundation, an organization founded by de Grey to promote anti-aging science, pledged the other half.) 

The full versions of all three submissions to the SENS Challenge, with full citations and footnotes, can be found below.
Estep et al. strongly disagreed with the judges's opinion. Read their dissent here.

Also read it for the long, long, long dialog that follows the Dissent between De Grey and Dave Whitlock.

The winners are donating the entire $10,000 prize to the American Federation for Aging Research.


Submission 2:
Stop Making SENS Bret Weinstein, Ph.D. candidate

> Rebuttal by Aubrey de Grey
> Counter Response
Crabsallover suggests 'Read Submission 3 and the Rebuttal and Counter Response (including online debate between Estep, De Grey et al.)'

Wednesday, 20 October 2010

Methuselah Foundation - extending healthy human life


reposted from: http://www.mfoundation.org/


Our Mission: Significantly extend the healthy lifespan of humanity.
Instead of accepting the physical and mental losses associated with aging we look for answers and solutions. Not for one disease but for the general loss of functionality and productivity that we all experience. We are a catalyst for progress - seeking, supporting and rewarding science that extends healthy lifespan.
Methuselah Foundation is a non-profit medical charity dedicated to extending healthy human life through proven programs such as the Mprize, My Bridge 4 Life, and a diverse support of key technology and research generated by companies like SENS, Organovo, and Silverstone Solutions.
The Mprize, introduced in 2003, is designed to directly accelerate the development of revolutionary new life extension therapies. 






MPrize There are two categories of MPrize cash prizes:
  • Longevity - to the research team that breaks the world record for the oldest-ever mouse
  • Rejuvenation - to the team that develops the most successful late-onset rejuvenation that extends the life of the mice
NewOrganPrize - Expediting the Solution to Organ Failure: We challenge scientists to duplicate and successfully transplant a fully functioning new organ made from a patient's own cells by 2020.

A SYSTEM FOR THE FUTURE: NEWORGANOMICS

We envision a world where everyone who needs an organ gets an organ. And, in the Methuselah Foundation quest for everyone to live a long healthy life, we advocate a system that provides new organs and long-term health. We call that system NewOrganomics.
The promise of NewOrganomics is to provide a new organ to any patient in need, not from a donor or from the black market but rather built from their own cells. NewOrgan Prize was created to reach this ambitious goal. We need your support to make it happen. Be Organomical, donate today.






Methuselah Foundation continuously and vigorously scans the horizons for high impact efforts that meet all of our criteria and show significant promise for extending healthy human life and eliminating the diseases of aging.
We are currently providing support for these companies working in research and development of long term life extension solutions.
Organovo, Inc. is a regenerative medicine company that applies proprietary technology to "print" new organs. Their work will enable us to quickly and cheaply produce organs and body tissue for transplantation and testing, thereby reducing the need for animal test subjects and greatly speeding up the process by which treatments can used for humans.

The SENS Foundation research programs invest directly into specific scientific research, aimed at the biomedical repair of the damage of biological aging. Using a revolutionary "engineering" approach, these therapies will repair all known forms of aging-related damage in the human body, with the aim of restoring youthful cellular and biomolecular structure, renewing youthful function, health, and vitality. Listen to Aubrey de Grey explain the SENS approach here.
SENS Foundation was launched in March, 2009 as a new and independent organization (prior to that it was part of the Methuselah Foundation), with a mission to develop, promote and ensure widespread access to regenerative medicine solutions to the disabilities and diseases of aging and the Methuselah Foundation subsequently transferred its SENS research initiatives, along with supportive grant funding, to SENS Foundation.
To learn more about the SENS solution visit SENS.org.






"It seems a cruel joke that just when we've finally lived long enough to become wise, we begin the great decline into physical and mental deterioration that eventually leads to death. This is a travesty not only for individuals but for mankind as a whole." Royal-Gordon Family 300 MEMBERS

"There are 56 million people dying every year, 150 thousand every day, two people every second. The wisest, the best, the most experienced leave us, often in painful conditions. This is tragic, sad and inhumane. I believe we can change it and each donation will speed up the fight."
Maciek Kolodziejczyk 300 MEMBER